Edit |   |
---|---|
Antigenic Specificity | NM23-H1/NME1, Human |
Clone | AT5F4 |
Host Species | Mouse |
Reactive Species | human |
Isotype | IgG2b kappa |
Format | Protein A purified |
Size | 50ul, 100ul |
Concentration | 1mg/ml (determined by BCA assay) |
Applications | ELISA, WB, ICC/IF |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Non-metastatic cells 1 (NME1), also known as NM23-H1, originally identified as a candidate metastasis suppressor gene. NME1 is expressed in different tumor types where their levels have been alternatively associated with reduced or increased metastatic potential. Reductions in NME1 expression have been significantly associated with aggressive behavior in melanoma, breast, colon, and gastric carcinomas. On the contrary, high levels of NME1 gene expression are noted in the advanced stage of thyroid carcinomas. |
Immunogen | Recombinant human NME1 (1-152aa) purified from E. coli |
Other Names | NME/NM23 nucleoside diphosphate kinase 1, Nucleoside diphosphate kinase A, Granzyme A-activated Dnase, GAAD, Metastasis inhibition factor nm23, NM23-H1, Tumor metastatic process-associated protein, NDK A, NDP kinase A, NDPKA, NM23 |
Gene, Accession # | NCBI: NP_000260, UniProt: P15531 |
Catalog # | ATGA0461 |
Price | $170, $290 |
Order / More Info | NM23-H1/NME1, Human Antibody from NKMAX Co. Ltd. |
Product Specific References | n/a |